Saeki H, Shimada Y, Ohki E, Sugawara S
J Antibiot (Tokyo). 1975 Jul;28(7):530-6. doi: 10.7164/antibiotics.28.530.
5"-Amino-3',4'5"-trideoxybutirosin A (4) was synthesized by two routes starting from the known tri-O-acetyl-tetra-N-benzyloxycarbonyl-3",5"-O-cyclohexylidene-3',4'-di-O-mesylbutirosin A (5). Introduction of amino function at C-5" was carried out by displacement of 5"-tosyloxy group with sodium azide either before or after 3',4'-deoxygenation. Compound 4 shows outstanding activities against strains including Pseudomonas aeruginosa and Escherichia coli which are highly resistant to butirosin and 5"-amino-5"-deoxybutirosin A (2).
5’-氨基-3’,4’,5”-三脱氧丁胺卡那霉素A(4)通过两条路线合成,起始原料为已知的三-O-乙酰基-四-N-苄氧羰基-3”,5”-O-亚环己基-3’,4’-二-O-甲磺酰丁胺卡那霉素A(5)。在3’,4’-脱氧之前或之后,用叠氮化钠取代5”-甲苯磺酰氧基,从而在C-5”处引入氨基官能团。化合物4对包括铜绿假单胞菌和大肠杆菌在内的菌株表现出优异的活性,这些菌株对丁胺卡那霉素和5”-氨基-5”-脱氧丁胺卡那霉素A(2)具有高度抗性。